VRDNNasdaq

Viridian Therapeutics, Inc.\DE

Alert me on VRDN

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Aug 21 Sale Tousignant Jennifer Insider

1 week

−5.0%S&P +0.5%

1 month

−8.9%S&P +1.3%

3 months

Result in13 trading days

6 months

Result in76 trading days

May 14 Buy Fairmount Funds Management LLC Insider

1 week

+1.5%S&P −0.7%

1 month

−6.5%S&P +0.9%

3 months

+26.7%S&P +4.0%

6 months

Result in8 trading days

May 14 Buy Fairmount Healthcare Fund II GP LLC Insider

1 week

+1.5%S&P −0.7%

1 month

−6.5%S&P +0.9%

3 months

+26.7%S&P +4.0%

6 months

Result in8 trading days

May 14 Buy Fairmount Healthcare Fund II L.P. Insider

1 week

+1.5%S&P −0.7%

1 month

−6.5%S&P +0.9%

3 months

+26.7%S&P +4.0%

6 months

Result in8 trading days

Jan 3 Sale Tousignant Jennifer Insider

1 week

+7.8%S&P +1.1%

1 month

+0.6%S&P −0.2%

3 months

−53.8%S&P −3.9%

6 months

−34.2%S&P +9.0%

Show all 8

Oct 28, 2025 Buy Fairmount Funds Management LLC Insider

1 week

−2.7%S&P −1.7%

1 month

+36.9%S&P −1.1%

3 months

+44.9%S&P +1.3%

6 months

−41.8%S&P +5.2%

Oct 28, 2025 Buy Fairmount Healthcare Fund II GP LLC Insider

1 week

−2.7%S&P −1.7%

1 month

+36.9%S&P −1.1%

3 months

+44.9%S&P +1.3%

6 months

−41.8%S&P +5.2%

Oct 28, 2025 Buy Fairmount Healthcare Fund II L.P. Insider

1 week

−2.7%S&P −1.7%

1 month

+36.9%S&P −1.1%

3 months

+44.9%S&P +1.3%

6 months

−41.8%S&P +5.2%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for VRDN

43 held · newest 543 held · newest 2

Loading the filings.

See all 43 filings for VRDN

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Aug 19, 2026 Schedule 13G

Point72 Asset Management, L.P.: 5%, 5,687,507 shares

Jun 30, 2026 Schedule 13G, amended

Paradigm BioCapital Advisors LP: 6.1%, 6,723,788 shares

Jun 30, 2026 Schedule 13G, amended

Kynam Capital Management, LP: 5.7%, 0 shares

Jun 30, 2026 Schedule 13G

T. Rowe Price Associates, Inc.: 5.2%, 5,748,426 shares

Jun 30, 2026 Schedule 13G, amended

Deep Track Capital, LP: 3.3%, 3,592,740 shares

Jun 30, 2026 Schedule 13G

STATE STREET CORPORATION: 5.5%, 6,124,976 shares

Jun 18, 2026 Schedule 13G

Paradigm BioCapital Advisors LP: 5.1%, 5,633,788 shares

Mar 31, 2026 Schedule 13G

Bellevue Group AG: 6.6%, 6,726,144 shares

May 11, 2026 Schedule 13D, amended

Fairmount Funds Management LLC: 14%, 17,201,800 shares

May 1, 2026 Schedule 13G

Deep Track Capital, LP: 5.3%, 5,417,660 shares

Mar 13, 2026 Schedule 13G, amended

The Vanguard Group: 0%, 0 shares

Dec 31, 2025 Schedule 13G, amended

Kynam Capital Management, LP: 1.5%, 1,470,541 shares

Dec 31, 2025 Schedule 13G, amended

Deep Track Capital, LP: 2.6%, 2,524,833 shares

Sep 30, 2025 Schedule 13G, amended

Commodore Capital LP: 3.9%, 3,200,000 shares

Oct 23, 2025 Schedule 13D, amended

Fairmount Funds Management LLC: 15.1%, 16,025,330 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.